Cargando…

Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland

BACKGROUND: Hazardous alcohol consumption and HIV infection increase the risk of neurocognitive impairment (NCI). We examined the association between alcohol consumption and specific neurocognitive domain function in people with HIV (PWH) taking modern antiretroviral therapy. METHODS: The Neurocogni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darling, Katharine E. A., Locatelli, Isabella, Benghalem, Nadia, Nadin, Isaure, Calmy, Alexandra, Gutbrod, Klemens, Hauser, Christoph, Brugger, Peter, Hasse, Barbara, Kovari, Helen, Kunze, Ursi, Stoeckle, Marcel, Fux, Christophe, Rossi, Stefania, Di Benedetto, Caroline, Früh, Severin, Schmid, Patrick, Tarr, Philip E., Daeppen, Jean-Bernard, Du Pasquier, Renaud, Cavassini, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924787/ https://www.ncbi.nlm.nih.gov/pubmed/33651794 http://dx.doi.org/10.1371/journal.pone.0246579

Ejemplares similares

Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
por: Santos, Galia M A, et al.
Publicado: (2019)

Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
por: Damas, José, et al.
Publicado: (2021)

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile
por: Métral, M, et al.
Publicado: (2019)

How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well‐treated HIV‐positive population?
por: Metral, M, et al.
Publicado: (2019)

Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
por: Jakeman, Bernadette, et al.
Publicado: (2022)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Reasons for late presentation to HIV care in Switzerland
por: Hachfeld, Anna, et al.
Publicado: (2015)

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
por: Bouatou, Yassine, et al.
Publicado: (2018)

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
por: Gueler, Aysel, et al.
Publicado: (2017)

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
por: Surial, Bernard, et al.
Publicado: (2019)

Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
por: Kenfak-Foguena, Alain, et al.
Publicado: (2011)

Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field
por: Granziera, Cristina, et al.
Publicado: (2013)

Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland
por: Kaufmann, Annatina, et al.
Publicado: (2011)

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
por: Thoueille, Paul, et al.
Publicado: (2022)

Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis
por: Bandiera, Carole, et al.
Publicado: (2022)

Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study
por: Blondet, Fanny, et al.
Publicado: (2023)

Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012
por: Kovari, Helen, et al.
Publicado: (2013)

Mortality in Switzerland in 2021
por: Locatelli, Isabella, et al.
Publicado: (2022)

Awareness of HIV Testing Guidelines Is Low among Swiss Emergency Doctors: A Survey of Five Teaching Hospitals in French-Speaking Switzerland
por: Darling, Katharine E. A., et al.
Publicado: (2013)

Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
por: Zeeb, Marius, et al.
Publicado: (2023)

Technological, Organizational, and Environmental Factors Influencing Social Media Adoption by Hospitals in Switzerland: Cross-Sectional Study
por: Beier, Michael, et al.
Publicado: (2020)

Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study
por: Mauri, Fabio, et al.
Publicado: (2022)

Impact of HPV vaccination with Gardasil® in Switzerland
por: Jacot-Guillarmod, Martine, et al.
Publicado: (2017)

Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study
por: Bosetti, Davide, et al.
Publicado: (2022)

Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland
por: Deline, Stéphane, et al.
Publicado: (2014)

A first analysis of excess mortality in Switzerland in 2020
por: Locatelli, Isabella, et al.
Publicado: (2021)

Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy
por: Barceló, Catalina, et al.
Publicado: (2020)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study
por: Hasse, Barbara, et al.
Publicado: (2014)

Two complementary approaches to estimate an excess of mortality: The case of Switzerland 2022
por: Locatelli, Isabella, et al.
Publicado: (2023)

Reactivation of Bovine Tuberculosis in Patient Treated with Infliximab, Switzerland
por: Nager, Marina, et al.
Publicado: (2009)

Mortality from suicide among people living with HIV and the general Swiss population: 1988‐2017
por: Ruffieux, Yann, et al.
Publicado: (2019)

Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography
por: Tarr, Philip E, et al.
Publicado: (2020)

Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population
por: Hasse, Barbara, et al.
Publicado: (2015)

Predicting the burden of cancer in Switzerland up to 2025
por: Trächsel, Bastien, et al.
Publicado: (2022)

Increases in Condomless Sex in the Swiss HIV Cohort Study
por: Kouyos, Roger D., et al.
Publicado: (2015)

Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)
por: Hachfeld, Anna, et al.
Publicado: (2021)

Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study
por: Courvoisier, Nelly, et al.
Publicado: (2022)

Mobilizing agencies for incidence surveys on child maltreatment: successful participation in Switzerland and lessons learned
por: Jud, Andreas, et al.
Publicado: (2018)

Inappropriate use of arthroscopic meniscal surgery in degenerative knee disease: An observational study from Switzerland
por: Muheim, Leander L S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lkr8073u9th9e8eoilca0mk0el